Tag: Brainomix 360 platform
New data presented at ISC 2025 further validate treatment impact of...
Brainomix will be unveiling a series of new studies this week at the International Stroke Conference (ISC; 5–7 February, Los Angeles, USA), further validating...
Brainomix targets US expansion following launch of 360 platform at SVIN...
Brainomix has heralded its continued US expansion with the launch of a full suite of US Food and Drug Administration (FDA)-cleared modules in its...
